Matt Gaylord



Matt currently serves as the Director of Business Development within a large, growing MedTech enterprise. In this role, Matt operates as a corporate venture capitalist and is responsible for growing, managing, and establishing the enterprise’s strategic investment portfolio. Matt has held this position for several years now and has successfully completed a multitude of transactions, including: priced seed, A, B, C, and D rounds; convertible financings; concurrent IPO placements; and outright business acquisitions. Matt’s career began as a biomedical engineer, having graduated from Tufts University with Mechanical Engineering and Biomedical Engineering degrees. Matt was a ground-floor employee of Serica Technologies, which was acquired by Allergan Medical in 2010. After several years of continued product development and a successful commercial launch within Allergan, Matt left to attend Business School at Duke University’s Fuqua School of Business where he graduated with a MBA, receiving a certificate in Healthcare Sector Management and a concentration in Financial Analyses. Following business school and before rejoining the MedTech industry, Matt worked in a strategic consulting role for PricewaterhouseCoopers’ Healthcare Industry Advisory group, focusing primarily on big pharma operational efficiencies, M&A, post-merger integrations, and market expansion/entry.